Skip to main content
SpringerLink
Log in

Stimulants—Including Cocaine

  • Chapter
Drug and Alcohol Abuse

Part of the book series: Critical Issues in Psychiatry ((CIPS))

  • 371 Accesses

Abstract

Stimulants are widely prescribed and greatly misused medications that have few bona fide medical uses. It is important that the clinician know these drugs well, as their misuse can mimic a variety of medical and psychiatric syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. King, G. R., & Ellinwood, E. H. Amphetamines and other stimulants. In J. H. Lowinson, P. Ruiz, R. B. Mill-man, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 207–223.

    Google Scholar 

  2. Chait, L. D. Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 113:381–387, 1994.

    PubMed  Google Scholar 

  3. Ellinwood, E. H., & Lee, T. H. Psychopathology and treatment of amphetamine abuse. In H. Rommelspocher & M. Schuckit (Eds.), Bailliere’s clinical psychiatry: Drugs of abuse. London: Bailliere Tindall, 1996, pp. 487–501.

    Google Scholar 

  4. Gold, M. S., & Herkov, M. J., The pharmacology of cocaine, crack and other stimulants. In A. W. Graham, T. K. Schultz, & B. B. Wilford (Eds.), Principles of addiction medicine (2nd ed.). Chevy Chase, MD: American Society of Addiction Medicine, 1998, pp. 137–146.

    Google Scholar 

  5. Woody, G. E., Mercer, D. E., & Auriacombe, M. Cocaine use disorders. In H. Rommelspocher & M. Schuckit (Eds.), Bailliere’s clinical psychiatry: Drugs of abuse. London: Bailliere Tindall, 1996, pp. 461–479.

    Google Scholar 

  6. O’Brien, C. P. Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 557–577.

    Google Scholar 

  7. Gold, M. S. Cocaine (and crack): Clinical aspects. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 181–199.

    Google Scholar 

  8. Gold, M. S., & Miller, N. S. Cocaine (and crack): Neurobiology. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 166–181.

    Google Scholar 

  9. Klee, H. (Ed.). Amphetamine misuse: International perspectives on current trends. Amsterdam: Harwood Academic Publishers, 1997.

    Google Scholar 

  10. Sato, M., Chen, C. C., Akiyama, S., & Otsuki, S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry 18:429–440, 1983.

    PubMed  Google Scholar 

  11. Winger, G., Hofmann, F. G., & Woods, J. H. A handbook on drug and alcohol abuse (3rd ed.). New York: Oxford University Press, 1992, pp. 132–149.

    Google Scholar 

  12. Cho, A. K. Ice: A new dosage form of an old drug. Science 249:631–634, 1990.

    PubMed  Google Scholar 

  13. Kaufman, M. J., Levin, J. M., Ross, M. H., et al. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. Journal of the American Medical Association 279:376–380, 1998.

    PubMed  Google Scholar 

  14. Morgan, J. P. Designer drugs. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 264–269.

    Google Scholar 

  15. Griffiths, P. Qat use in London: a study of qat use among a sample of Somalis living in London. United Kingdom: Central Drugs Prevention Unit, 1998.

    Google Scholar 

  16. Al-Meshal, I. A. The toxicity of khat in mice. Journal of Substance Abuse 3:107–115, 1991.

    PubMed  Google Scholar 

  17. Griffiths, P., Gossop, M., Wickenden, S., et al. A transcultural pattern of drug use: Qat (khat) in the UK. British Journal of Psychiatry, 170:281–284, 1997.

    PubMed  Google Scholar 

  18. O’Dell, L. E., Sussman, A. N., Meyer, K. L., & Neisewander, J. L. Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei. Neuropsychopharmacology 20:591–602, 1999.

    PubMed  Google Scholar 

  19. Kovar, K. A., Gouzoulis, E., & Hermle, L. Amphetamines. In H. Rommelspocher & M. Schuckit (Eds.), Bailliere’s clinical psychiatry: Drugs of abuse. London: Bailliere Tindall, 1996, pp. 479–488.

    Google Scholar 

  20. Jaffe, J. H. Amphetamine (or amphetaminelike)-related disorders. In H. I. Kaplan & B. J. Saddock (Eds.), Comprehensive textbook of psychiatry (6th ed.). Baltimore, MD: Williams & Wilkins, 1995, pp. 791–799.

    Google Scholar 

  21. Mendelson, J. H., & Mello, N. K. Cocaine and other commonly abused drugs. In A. S. Fauci, E. Braunwald, K. J. Isselbacher, et al. (Eds.), Harrison’s principles of internal medicine (14th ed.). New York: McGraw-Hill, 1998, pp. 2512–2516.

    Google Scholar 

  22. Weissman, N. J., Tighe, J. F. Jr., Gottdiener, J. S., & Gwynne, J. T. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. New England Journal of Medicine 339:725–732, 1998.

    PubMed  Google Scholar 

  23. Volkow, N. D., Wang, G.-J., Fowler, J. S., et al. Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors. American Journal of Psychiatry 154:50–55, 1997.

    PubMed  Google Scholar 

  24. Volkow, N. D., Wang, G. J., Fowler, J. S., et al. Dopamine transported occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry 155:1325–1331, 1998.

    PubMed  Google Scholar 

  25. Irwin, M. Cocaine and amphetamine: Psychostimulant abuse. In T. Widiger, A. Frances, H. Pincus, M. First, & W. Davis (Eds.), The DSM-IV Sourcebook, Vol 1. Washington, DC: American Psychiatric Press, 1994, pp. 169–179.

    Google Scholar 

  26. American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed. Washington, DC: American Psychiatric Press, 1994.

    Google Scholar 

  27. Little, K. Y., McLayghlin, D. P., Zhang, L., et al. Brain dopamine transporter messenger RNA and binding sites in cocaine users. Archives of General Psychiatry 55:793–799, 1998.

    PubMed  Google Scholar 

  28. Segal, D. S., & Kuczenski, R. An escalating dose “binge” model of amphetamine psychosis: Behavioral and neurochemical characteristics. The Journal of Neuroscience 17:2551–2566, 1997.

    PubMed  Google Scholar 

  29. Volkow, N. D., Wang, G.-J., Fowler, J. S., et al. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A PET study. American Journal of Psychiatry 155:200–206, 1998.

    PubMed  Google Scholar 

  30. Volkow, N. D., Wang, G.-J., Fowler, J. S., et al. Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology 14:159–168, 1996.

    PubMed  Google Scholar 

  31. Little, K. Y., Zhang, L., Desmond, T., et al. Striatal dopaminergic abnormalities in human cocaine users. American Journal of Psychiatry 156:238–245, 1999.

    PubMed  Google Scholar 

  32. McCreary, A. C., & Cunningham, K. A. Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20:556–564, 1999.

    PubMed  Google Scholar 

  33. Buydens-Branchey, L., Branchey, M., Hudson, J., et al. Serotonergic function in cocaine addicts: Prolactin responses to sequential D, L-fenfluramine challenges. Biological Psychiatry 45:1300–1306, 1999.

    PubMed  Google Scholar 

  34. Betancur, C., Cabrera, R., De Kloet, E. R., et al. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine. Neuropsychopharmacology 19:322–332, 1998.

    PubMed  Google Scholar 

  35. Pearlson, G. D., Jeffery, P. J., Harris, G. J., et al. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. American Journal of Psychiatry 150:495–497, 1993.

    PubMed  Google Scholar 

  36. Johnson, B., Lamki, L., Fang, B., et al. Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology 18:377–384, 1998.

    PubMed  Google Scholar 

  37. Mathew, R. J., Wilson, W. H., Lowe, J. V., & Humphries, D. Acute changes in cranial blood flow after cocaine hydrochloride. Biological Psychiatry 40:609–616, 1996.

    PubMed  Google Scholar 

  38. Schlaepfer, T. E., Pearlson, G. D., Wong, D. F., et al. PET study of competition between intravenous cocaine and [11C]Raclopride at dopamine receptors in human subjects. American Journal of Psychiatry 154:1209–1213, 1997.

    PubMed  Google Scholar 

  39. Buydens-Branchey, L., Branchey, M., Fergeson, P., et al. The metachlorophenylpiperazine challenge test in cocaine addicts: Hormonal and psychological responses. Biological Psychiatry 41:1071–1086, 1997.

    PubMed  Google Scholar 

  40. Malison, R. T., Best, S. E., van Dyck, C. H., et al. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I]b-CIT SPECT. American Journal of Psychiatry 155:832–834, 1998.

    PubMed  Google Scholar 

  41. Childress, A. R., Mozley, P. D., McElgin, W., et al. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 156:11–18. 1999.

    PubMed  Google Scholar 

  42. Volkow, N. D., Fowler, J. S., & Wolf, A. P. Use of PET to study cocaine in the human brain. In R. Rapaka, A. Makriyannis, & M. J. Kuhar (Eds.), Emerging technologies and new directions in drug abuse research. NIDA Research Monograph 112:168-179, 1991.

    Google Scholar 

  43. Wu, J. C., Bell, K., Najafi, A., et al. Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology 17:402–409, 1997.

    PubMed  Google Scholar 

  44. Roy, M., Roy, A., Smelson, D., et al. Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: A replication. Biological Psychiatry 42:631–633, 1997.

    PubMed  Google Scholar 

  45. Giros, B., Jaber, M., Jones, S. R., et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612, 1996.

    PubMed  Google Scholar 

  46. Seale, T. W Genetic differences in response to cocaine and stimulant drugs. In J. C. Crabbe & R. A. Harris (Eds.), The genetic basis of alcohol and drug actions. New York: Plenum Press, 1991, pp. 279–321.

    Google Scholar 

  47. Morgan, M. J., Cascella, N. G., Stapleton, J. M., et al. Sensitivity to subjective effects of cocaine in drug abusers: Relationship to cerebral ventricle size. American Journal of Psychiatry 150:1712–1717, 1993.

    PubMed  Google Scholar 

  48. Kendler, K. S., & Prescott, C. A. Cocaine use, abuse and dependence in a population-based sample of female twins. British Journal of Psychiatry 173:345–350, 1998.

    PubMed  Google Scholar 

  49. Negus, S. S., Gatch, M. B., & Mello, N. K. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 18:325–338, 1998.

    PubMed  Google Scholar 

  50. Pecins-Thompson, M., & Peris, J. Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration. Psychopharmacology 110:443–450, 1993.

    PubMed  Google Scholar 

  51. Higgins, S. T., Rush, C. R., Hughes, J. H., et al. Effects of cocaine and alcohol, alone and in combination, on human learning and performance. Journal of the Experimental Analysis of behavior 58:87–105, 1992.

    PubMed  Google Scholar 

  52. Randall, T. Cocaine, alcohol mix in body to form even longer lasting, more lethal drug. Journal of the American Medical Association 267: 1043–1044, 1992.

    PubMed  Google Scholar 

  53. McCance-Katz, E. F., Kosten, T. R., & Jatlow, P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone—A multiple-dose study. Biological Psychiatry 44:250–259, 1998.

    PubMed  Google Scholar 

  54. Cocores, J., Pottash, A. C., & Gold, M. S. Cocaine. In N. S. Miller (Ed.), Comprehensive handbook of drug and alcohol addiction. New York: Marcel Dekker, 1991, pp. 341–352.

    Google Scholar 

  55. Fischman, M. W., & Foltin, R. W. A comparison of the effects of smoked and intravenous cocaine in humans. Paper presented at the ACNP Annual Meeting, Maui, Hawaii, December 12, 1989.

    Google Scholar 

  56. Zwerling, C., Ryan, J., & Orav, E. J. The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. Journal of the American Medical Association 264:2639–2643, 1990.

    PubMed  Google Scholar 

  57. Higgins, S. T., Bickel, W. K., Hughes, J. R., et al. Effects of intranasal cocaine on human learning, performance and physiology. Psychopharmacology 102:451–458, 1990.

    PubMed  Google Scholar 

  58. Salloum, I. M., Daley, D. C., Cornelius, J. R., et al. Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse. American Journal of Psychiatry 153:953–955, 1996.

    PubMed  Google Scholar 

  59. Byck, R. The effects of cocaine on complex performance in humans. Alcohol, Drugs, and Driving 3:9–11, 1987.

    Google Scholar 

  60. Mendelson, J. H., Sholar, M., Mello, N. K., et al. Cocaine tolerance: Behavioral, cardiovascular, and neu-roendochrine function in men. Neuropsychopharmacology 18:263–271, 1998.

    PubMed  Google Scholar 

  61. Woolverton, W. L., Kandel, D., & Schuster, C. R. Tolerance and cross-tolerance to cocaine and D-amphetamine. Journal of Pharmacological and Experimental Therapeutics 205:525–535, 1979.

    Google Scholar 

  62. Fraioli, S., Crombag, H. S., Badiani, A., & Robinson, T. E. Susceptibility to amphetamine-induced locomotor sensitization is modulated by environmental stimuli. Neuropsychopharmacology 20:533–541, 1999.

    PubMed  Google Scholar 

  63. Huang, Y.-H., Tsai, S.-J., Wang, Y.-C., et al. Differential development of the enhanced metabolic response during amphetamine sensitization. Neuropsychobiology 36:177–181, 1997.

    PubMed  Google Scholar 

  64. White, F. J., Joshi, A., Koeltzow, T. E., & Hu, X.-T. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18:26–40, 1998.

    PubMed  Google Scholar 

  65. Friedman, A. S., & Cacciola, J. Validation of the criteria for DSM diagnoses of cocaine abuse and cocaine dependence. American Journal of Drug and Alcohol Abuse 24:169–177, 1998.

    PubMed  Google Scholar 

  66. American Psychiatric Association. The diagnostic and statistical manual of mental disorders (3rd ed. rev.). Washington, DC: American Psychiatric Press, 1987.

    Google Scholar 

  67. Schuckit, M. A., Daeppen, J.-B., Danko, G. P., et al. The clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. American Journal of Psychiatry 156:41–49, 1999.

    PubMed  Google Scholar 

  68. Maas, L. C., Lukas, S. E., Kaufman, M. J., et al. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. American Journal of Psychiatry 155:124–126, 1998.

    PubMed  Google Scholar 

  69. Liu, X., Vaupel, D. B., Grant, S., & London, E. D. Effect of cocaine-related environmental stimuli on the spontaneous electroencephalogram in polydrug abusers. Neuropsychopharmacology 19:10–17, 1998.

    PubMed  Google Scholar 

  70. Herning, R. I., Guo X., Better, W E., et al. Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal. Biological Psychiatry 41:1087–1094, 1997.

    PubMed  Google Scholar 

  71. Prichep, L. S., Alper, K. R., Kowalik, S., et al. Quantitative electroencephalographic characteristics of crack cocaine dependence. Biological Psychiatry 40:986–993, 1996.

    PubMed  Google Scholar 

  72. Alper, K. R., Prichep, L. S., Kowalik, S., et al. Persistent EEG abnormalities in crack cocaine users at 6 months of drug abstinence. Neuropsychopharmacology 19:1–9, 1998.

    PubMed  Google Scholar 

  73. Tran-Nguyen, T. L., Fuchs, R. A., Coffey, G. P., et al. Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19:48–59, 1998.

    PubMed  Google Scholar 

  74. Mitler, M. M., Guilleminault, E., Harsh, C., & Hirshkowitz, M. Randomized trial of moodafinil for the treatment of narcolepsy. Annals of Neurology 43:88–97, 1998.

    Google Scholar 

  75. Matochik, J. A., Nordahl, T. E., Gross, M., et al. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 8:377–386, 1993.

    PubMed  Google Scholar 

  76. Biederman, J., Wilens, T. E., Mick, E., et al. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry 44:269–273, 1998.

    PubMed  Google Scholar 

  77. Stunkard, A. J., Stinnett, J. L., & Smoller, J. W. Psychological and social aspects of the surgical treatment of obesity. American Journal of Psychiatry 143:417–429, 1986.

    PubMed  Google Scholar 

  78. McCann, U. D., Seiden, L. S., Rubin, L. J., & Ricaurte, G. A. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: A systematic review of the evidence. Journal of the American Medical Association 278:666–672, 1997.

    PubMed  Google Scholar 

  79. Palumbo, J. M., Gold, M. S., & Pottash, A. C. Cocaine: Epidemiology. In N.S. Miller (Ed.), Comprehensive handbook of drug and alcohol addiction. New York: Marcel Dekker, 1991, pp. 125–130.

    Google Scholar 

  80. Angrist, B. M., & Gershon, S. Psychiatric sequelae of amphetamine use. In R. I. Shader (Ed.), Psychiatric complications of medical drugs. New York: Raven Press, 1972, pp. 23–35.

    Google Scholar 

  81. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National household survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  82. Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use from the Monitoring the Future study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  83. Crits-Christoph, P., & Siqueland, L. Psychosocial treatment for drug abuse. Archives of General Psychiatry 53:149–156, 1996.

    Google Scholar 

  84. Royo-Bordonada, M. A., Cid-Ruzafa, J., Martin-Moreno, J. M., & Guallar, E. Drug and alcohol use in Spain: Consumption habits, attitudes and opinions. Public Health 111:277–284, 1997.

    PubMed  Google Scholar 

  85. Florenzano, R., Pino, P., & Marchandon, A. Risk behavior in adolescent students in Santiago de Chile. Re-vista Medica de Chile 121:462–469, 1993.

    Google Scholar 

  86. Mora, M. E., Villatoro, J., & Rojas, E. Drug use among students in Mexico’s northern border states. In Department of Health and Human Services, Epidemiologic trends in drug abuse. Washington, DC: U.S. Government Printing Office, 1996, pp. 367–375.

    Google Scholar 

  87. Griffin, M. L., Weiss, R. D., Mirin, S. M., & Lange, U. A comparison of male and female cocaine abusers. Archives of General Psychiatry 46:122–126, 1989.

    PubMed  Google Scholar 

  88. Vincent, N., Shoobridge, J., Ask, A., et al. Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review 18:63–73, 1999.

    Google Scholar 

  89. Carroll, K. M., & Rounsaville, B. J. Contrast of treatment-seeking and untreated cocaine abusers. Archives of General Psychiatry 49:464–471, 1992.

    PubMed  Google Scholar 

  90. Komura, K., Hirai, S., & Sasahara, M. Treatment of methamphetamine-related disorders. In S. Fukui (Ed.), Cocaine and methamphetamine. Tokyo: Drug Abuse Prevention Center, 1991, pp. 346–354.

    Google Scholar 

  91. Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.

    Google Scholar 

  92. Schuckit, M. A. Alcohol, anxiety, and depressive disorders. Alcohol Health & Research World 20:81–85, 1996.

    Google Scholar 

  93. Tardiff, K., Marzuk, P. M., Leon, A. C., et al. Accidental fatal drug overdoses in New York City: 1990–1992. American Journal of Drug and Alcohol Abuse 22:135–146, 1996.

    PubMed  Google Scholar 

  94. Kosten, T. R., & Kleber, H. D. Sudden death in cocaine abusers: Relation to neuroleptic malignant syndrome. Lancet 1:1198–1199, 1987.

    PubMed  Google Scholar 

  95. McKelway, R., Vieweg, V., & Westerman, P. Sudden death from acute cocaine intoxication in Virginia in 1988. American Journal of Psychiatry 147:1667–1669, 1990.

    PubMed  Google Scholar 

  96. Kosten, T., & Kleber, H. Rapid death during cocaine abuse: A variant of the neuroleptic malignant syndrome? American Journal of Drug and Alcohol Abuse 14:335–346, 1988.

    PubMed  Google Scholar 

  97. Witkin, J. M., Johnson, R. E., Jaffe, J. H., et al. The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine. Drug and Alcohol Dependence 27:177–184, 1991.

    PubMed  Google Scholar 

  98. Catravas, J. D., Waters, I. W., Walz, M. A., & Davis, W. M. Antidotes for cocaine poisoning. New England Journal of Medicine 297:1238, 1977.

    PubMed  Google Scholar 

  99. Angrist, M. D., Less, H. K., & Gershon, S. The antagonism of amphetamine-induced symptomatology by a neuroleptic. American Journal of Psychiatry 131:817–819, 1974.

    PubMed  Google Scholar 

  100. Rappolt, R. T. Propranolol in cocaine toxicity. Lancet 2:640–641, 1976.

    PubMed  Google Scholar 

  101. Espelin, D. E., & Done, A. K. Amphetamine poisoning: Effectiveness of chlorpromazine. New England Journal of Medicine 278:1361–1365, 1978.

    Google Scholar 

  102. Weddington, W. W., Brown, B. S., Haertzen, C. A., et al. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Archives of General Psychiatry 47:861–868, 1990.

    PubMed  Google Scholar 

  103. Weiss, R. D., Hufford, C., & Mendelson, J. H. Serum prolactin levels and treatment outcome in cocaine dependence. Biological Psychiatry 35:573–574, 1994.

    PubMed  Google Scholar 

  104. Markou, A., & Koob, G. E. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsy-chopharmacology 4:17–26, 1991.

    Google Scholar 

  105. Swerdlow, N. R., Hauger, R., Irwin, M., et al. Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication. Neuropsychopharmacology 5:23–31, 1991.

    PubMed  Google Scholar 

  106. Gawin, F. H., & Kleber, H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Archives of General Psychiatry 43:107–133, 1986.

    PubMed  Google Scholar 

  107. Bauer, L. Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients. Alcoholism: Clinical and Experimental Research 20:1196–1201, 1996.

    Google Scholar 

  108. McKetin, R., & Solowij, N. Event-related potential indices of auditory selective attention in dependent amphetamine users. Biological Psychiatry 45:1488–1497, 1999.

    PubMed  Google Scholar 

  109. Bartzokis, G., Beckson, M., Hance, D. B., et al. Magnetic resonance imaging evidence of “silent” cerebrovascular toxicity in cocaine dependence. Biological Psychiatry 45:1203–1211, 1999.

    PubMed  Google Scholar 

  110. van Gorp, W. G., Wilkins, J. N., Hinkin, C. H., et al. Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry 56:85–89, 1999.

    PubMed  Google Scholar 

  111. Strickland, T. L., & Stein, R. A. Neurobehavioral functioning in chronic cocaine abusers following sustained abstinence. Archives of Clinical Neurology 11:456–457, 1996.

    Google Scholar 

  112. Aurigemma, G. P., & Gaasch, W. H. Valve disease and diet pills—Where do we stand? American Family Physician 57:659–660, 1998.

    Google Scholar 

  113. Aizenstein, M. L., Segal, D. S., & Kuczenski, R. Repeated amphetamine and fencamfamine: Sensitization and reciprocal cross-sensitization. Neuropsychopharmacology 3:283–290, 1990.

    PubMed  Google Scholar 

  114. Iyo, M. Pet dopamine D2 receptors and susceptibility to methamphetamine psychosis. Clinical Neuropharmacology 15:652A–653A, 1992.

    PubMed  Google Scholar 

  115. Rosse, R. B., Risher-Flowers, D., Peace, T., & Deutsch, S. I. Evidence of impaired smooth pursuit eye movement performance in crack cocaine users. Biological Psychiatry 31:1238–1240, 1992.

    PubMed  Google Scholar 

  116. Flaum, M., & Schultz, S. K. When does amphetamine-induced psychosis become schizophrenia? American Journal of Psychiatry 153:812–815, 1996.

    PubMed  Google Scholar 

  117. Sherer, M., Kumor, K., Golden, R., & Jaffe, J. Continuous infusion of cocaine—A model for cocaine psychosis? Paper presented at the Society of Biological Psychiatry Annual Meeting, Washington, D.C., May 10, 1986.

    Google Scholar 

  118. Ellinwood, E. H., Jr. Assault and homicide associated with amphetamine abuse. American Journal of Psychiatry 127:1170–1176, 1971.

    PubMed  Google Scholar 

  119. Perkins, K. A., Simpson, J. C., & Tsuang, M. T. Ten-year follow-up of drug abusers with acute or chronic psychosis. Hospital and Community Psychiatry 37:481–484, 1986.

    PubMed  Google Scholar 

  120. Goodwin, D. W., & Guze, S. B. Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1994.

    Google Scholar 

  121. Siegel, R. K. Cocaine hallucinations. American Journal of Psychiatry 135:309–314, 1978.

    PubMed  Google Scholar 

  122. Roberts, D. C., Dalton, J. C., & Vickers, G. J. Increased self-administration of cocaine following haloperi-dol: Effects of ovariectomy, estrogen replacement, and estrous cycle. Pharmacology, Biochemistry, and behavior 26:37–43, 1987.

    PubMed  Google Scholar 

  123. Kumor, K., Sherer, M., & Jaffe, J. Haloperidol-induced dystonia in cocaine addicts. Lancet 2:1341–1342, 1986.

    PubMed  Google Scholar 

  124. Gold, M. S. Cocaine (and crack): Clinical aspects. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 205–221.

    Google Scholar 

  125. Vincent, N., Shoobridge, J., Ask, A., et al. Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug and Alcohol Review 17:187–195, 1998.

    PubMed  Google Scholar 

  126. Hall, W., Hando, J., Darke, S., & Ross, J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 91:81–87, 1996.

    PubMed  Google Scholar 

  127. Aronson, T. A., & Craig, T. J. Cocaine precipitation of panic disorder. American Journal of Psychiatry 145:643–645, 1986.

    Google Scholar 

  128. Rosse, R. B., Fay-McCarthy, M., Collins, J. P., et al. Transient compulsive foraging behavior associated with crack cocaine use. American Journal of Psychiatry 150:155–156, 1993.

    PubMed  Google Scholar 

  129. Gillin, J. C., Pulvirenti, L., Withers, N., et al. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: A preliminary report. Biological Psychiatry 35:843–849, 1994.

    PubMed  Google Scholar 

  130. Schuckit, M. A., Tipp, J. E., Bucholz, K. K., et al. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 92:1289–1304, 1997.

    PubMed  Google Scholar 

  131. Lange, R. A., Cigarroa, R. G., Yancy, C. W., et al. Cocaine-induced coronary-artery vasoconstriction. The New England Journal of Medicine 321:1557–1562, 1989.

    PubMed  Google Scholar 

  132. Dow-Edwards, D. Fetal and maternal cocaine levels peak rapidly following intragastric administration in the rat. Journal of Substance Abuse 2:427–437, 1990.

    PubMed  Google Scholar 

  133. Hulse, G. K., English, D. R., Milne, E., et al. Maternal cocaine use and low birth weight newborns: A metaanalysis. Addiction 92:1561–1570, 1997.

    PubMed  Google Scholar 

  134. Vogel, G. Cocaine wreaks subtle damage on developing brains. Science 278:38–39, 1997.

    PubMed  Google Scholar 

  135. Budd, R. D. Cocaine abuse and violent death. American Journal of Drug and Alcohol Abuse 15:375–382, 1989.

    PubMed  Google Scholar 

  136. Boyer, C. S., & Petersen, D. R. Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcoholism: Clinical and Experimental Research 14:28–31, 1990.

    Google Scholar 

  137. Teoh, S. K., Woods, B. T., Anfinsen, P., et al. Pituitary volume in opioid and cocaine dependent men. Paper presented at the ACNP Annual Meeting, San Juan, December 10, 1991.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California Medical School and Veterans Affairs San Diego Healthcare System, San Diego, California, USA

    Marc A. Schuckit M. D. (Professor of Psychiatry)

Authors
  1. Marc A. Schuckit M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schuckit, M.A. (2000). Stimulants—Including Cocaine. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3232-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3232-0_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3234-4

  • Online ISBN: 978-1-4757-3232-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation